Cardiovascular-Kidney-Metabolic syndrome predicts the development of cardiovascular events in patients with rheumatoid arthritis: a 10-years prospective analysis from the CARMA cohort.
A metabolic risk syndrome predicts heart attacks more strongly in arthritis patients than general populations, arguing for routine risk screening in this group.
CKM syndrome significantly predicts cardiovascular events in rheumatoid arthritis with greater effect than in the general population, validated over 10 years in the CARMA cohort. This supports incorporation of CKM syndrome assessment into routine RA cardiovascular risk management.
What the study was
- Study design
- Prospective cohort (10-year follow-up)
- Population
- Rheumatoid arthritis patients and controls; n=704 RA + 604 controls (CARMA cohort); 10-year follow-up
- Sample size
- 1308
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- Seminars in arthritis and rheumatism
Why it surfaced
10-year prospective CARMA cohort; novel application of CKM syndrome to RA; addresses high CV burden in a specific at-risk population.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.